US Patent 7399853 Modulation of glucagon receptor expression

Patent 7399853 was granted and assigned to Ionis Pharmaceuticals on July, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Ionis Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7399853

Date of Patent

July 15, 2008

Patent Application Number

10832777

Date Filed

April 27, 2004

Patent Citations Received

‌

US Patent 11851655 Compositions and methods for modulating apolipoprotein (a) expression

Patent Primary Examiner

‌

Sean McGarry

Patent abstract

Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise oligonucleotides, targeted to nucleic acid encoding glucagon receptor. Methods of using these compounds for modulation of glucagon receptor expression and for diagnosis and treatment of disease associated with expression of glucagon receptor are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7399853 Modulation of glucagon receptor expression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API